We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Vasopressin Injection USP.
Press Release Aug 16 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Jul 06 2022
- Press Release Jun 07 2022
- Press Release May 26 2022
- Press Release May 03 2022
- Press Release Mar 17 2022
Later from Aurobindo Pharma
- Press Release Aug 24 2022
- Press Release Nov 12 2022
- Press Release Nov 18 2022
- Press Release Nov 23 2022
- Press Release Dec 27 2022
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma